So sánh Phẫu thuật Cận Giáp Trước và Sau Ghép Thận ở Bệnh Nhân Ghép Thận và Tác Động của Thời Điểm Phẫu Thuật Cận Giáp đến Chuyển Hóa Canxi và Chức Năng Ghép Thận: Phân Tích Từ Một Trung Tâm Đơn Lẻ

Block GA, Klassen PS, Lazarus JM et al (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208–2218 Reinhardt W, Bartelworth H, Jockenhövel F et al (1998) Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transpl 13:436–442 Pihlstrøm H, Dahle DO, Mjøen G et al (2015) Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism. Transplantation 99:351–359 Bleskestad IH, Bergrem H, Leivestad T et al (2014) Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function. Clin Transpl 28:479–486 Evenepoel P, Claes K, Kuypers DR et al (2007) Parathyroidectomy after successful kidney transplantation: a single centre study. Nephrol Dial Transpl 22:1730–1737 Schwarz A, Rustien G, Merkel S et al (2007) Decreased renal transplant function after parathyroidectomy. Nephrol Dial Transpl 22:584–591 Evenepoel P, Claes K, Kuypers D et al (2005) Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. Nephrol Dial Transpl 20:1714–1720 Littbarski SA, Kaltenborn A, Gwiasda J et al (2018) Timing of parathyroidectomy in kidney transplant candidates with secondary hyperparathryroidism: effect of pretransplant versus early or late post-transplant parathyroidectomy. Surgery 163:373–380 Jeon HJ, Kim YJ, Kwon HY et al (2012) Impact of parathyroidectomy on allograft outcomes in kidney transplantation. Transpl Int 25:1248–1256 Guideline Working Group, Japanese Society for Dialysis therapy (2008) Clinical practice guideline for the management of secondary hyperparathyroidism. Ther Apher Dial 6:514–525 Haas M, Sis B, Racusen LC et al (2014) Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transpl 14:272–283 Matsuo S, Imai E, Horio M et al (2009) Revised Equations for estimating glomerular filtration rate (GFR) from serum creatinine in Japan. Am J Kidney Dis 53:982–992 Cruzado JM, Moreno P, Torregrosa JV et al (2016) A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism. J Am Soc Nephrol 27:2487–2494 Chertow GM, Block GA, Correa-Rotter R et al (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367:2484–2494 Komaba H, Taniguchi M, Wada A et al (2015) Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney Int 88:350–359 Lee HH, Kim AJ, Ro H et al (2016) Sequential changes of vitamin D level and parathyroid hormone after kidney transplantation. Transpl Proc 48:897–899 Slatopolsky E, Finch J, Clay P et al (2000) A novel mechanism for skeletal resistance in uremia. Kidney Int 58:753–761 Åkerström G, Stålberg P, Surgical Management of Multiglandular Parathyroid Disease (2013) In: Randolph G (ed) Surgery of the thyroid and parathyroid glands, 2nd edn. Elsevier, Philadelphia, pp 620–638 Benz RL, Schleifer CR, Teehan BP et al (1989) Successful treatment of postparathyroidectomy hypocalcemia using continuous ambulatory intraperitoneal calcium (CAIC) therapy. Perit Dial Int. 9:285–288 Gutierrez O, Isakova T, Rhee E et al (2005) Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16:2205–2215 Saito H, Kusano K, Kinosaki M et al (2003) Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. J Biol Chem 278:2206–2211 Hsu CH, Patel SR, Young EW et al (1994) The biological action of calcitriol in renal failure. Kidney Int 46:605–612 Hamdy NA, Kanis JA, Beneton MN et al (1995) Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ 310:358–363 Rix M, Eskildsen P, Olgaard K (2004) Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure. Nephrol Dial Transpl 19:870–876 Coyne D, Acharya M, Qiu P et al (2006) Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. Am J Kidney Dis 47:263–276 Tominaga Y, Matsuoka S, Uno N et al (2010) Removal of autografted parathyroid tissue for recurrent renal hyperparathyroidism in hemodialysis patients. World J Surg 34:1312–1317. https://doi.org/10.1007/s00268-010-0412-9 Dreyer P, Ohe MN, Santos LM et al (2016) Parathyroid responsiveness during hypocalcemia after total parathyroidectomy and autotransplantation in patients with renal hyperparathyroidism. J Bras Nefrol 38:183–190 Massfelder T, Parekh N, Endlich K et al (1996) Effect of intrarenally infused parathyroid hormone-related protein on renal blood flow and glomerular filtration rate in the anaesthetized rat. Br J Pharmacol 118:1995–2000 de Zeeuw D, Agarwal R, Amdahl M et al (2010) Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 376:1543–1551 Andreev E, Koopman M, Arisz L (1999) A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible? J Intern Med 246:247–252 Parikh S, Nagaraja H, Agarwal A et al (2013) Impact of post-kidney transplant parathyroidectomy on allograft function. Clin Transpl 27:397–402 Rosen S, Greenfeld Z, Bernheim J et al (1990) Hypercalcemic nephropathy: chronic disease with predominant medullary inner stripe injury. Kidney Int 37:1067–1075 Peacock M (2002) Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum. J Bone Miner Res 17:87–94 Henegar JR, Coleman JP, Cespedes J et al (2003) Glomerular calcification in hypercalcemic nephropathy. Arch Pathol Lab Med 127:80–85 Suh JM, Cronan JJ, Monchik JM (2008) Primary hyperparathyroidism: is there an increased prevalence of renal stone disease? AJR Am J Roentgenol 191:908–911 Yamamoto T, Tominaga Y, Okada M et al (2016) Characteristics of persistent hyperparathyroidism after renal transplantation. World J Surg 40:600–606. https://doi.org/10.1007/s00268-015-3314-z Evenepoel P, Claes K, Kuypers D et al (2004) Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transpl 19:1281–1287 Evenepoel P, Kuypers D, Maes B et al (2001) Persistent hyperparathyroidism after kidney transplantation requiring parathyroidectomy. Acta Otorhinolaryngol Belg 55:17–186 Nakai K, Fujii H, Ishimura T et al (2017) Incidence and Risk Factors of Persistent Hyperparathyroidism After Kidney Transplantation. Transplant Proc. 49:53–56 Kikumori Imai T, Tanaka Y et al (1999) Parathyroid autotransplantation with total thyroidectomy for thyroid carcinoma: long-term follow-up of grafted parathyroid function. Surgery 125:504–508 Schneider R, Ramaswamy A, Slater EP et al (2012) Cryopreservation of parathyroid tissue after parathyroid surgery for renal hyperparathyroidism: does it really make sense? World J Surg 36:2598–2604. https://doi.org/10.1007/s00268-012-1730-x Tominaga Y, Katayama A, Sato T, et al (2003) Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients. Nephrol Dial Transplant. 18 Suppl 3:iii65–70